Integrative epigenomic and transcriptomic analyses reveal metabolic switching by intermittent fasting in brain

Geroscience. 2022 Aug;44(4):2171-2194. doi: 10.1007/s11357-022-00537-z. Epub 2022 Mar 31.

Abstract

Intermittent fasting (IF) remains the most effective intervention to achieve robust anti-aging effects and attenuation of age-related diseases in various species. Epigenetic modifications mediate the biological effects of several environmental factors on gene expression; however, no information is available on the effects of IF on the epigenome. Here, we first found that IF for 3 months caused modulation of H3K9 trimethylation (H3K9me3) in the cerebellum, which in turn orchestrated a plethora of transcriptomic changes involved in robust metabolic switching processes commonly observed during IF. Second, a portion of both the epigenomic and transcriptomic modulations induced by IF was remarkably preserved for at least 3 months post-IF refeeding, indicating that memory of IF-induced epigenetic changes was maintained. Notably, though, we found that termination of IF resulted in a loss of H3K9me3 regulation of the transcriptome. Collectively, our study characterizes the novel effects of IF on the epigenetic-transcriptomic axis, which controls myriad metabolic processes. The comprehensive analyses undertaken in this study reveal a molecular framework for understanding how IF impacts the metabolo-epigenetic axis of the brain and will serve as a valuable resource for future research.

Keywords: Cerebellum; Epigenetics; Intermittent fasting; Metabolism; Transcriptomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain
  • Epigenomics*
  • Fasting
  • Gene Expression Profiling
  • Transcriptome*